People

Chuck Cleland
Charles M. Cleland, PhD
CDUHR - Co-Director, Transdisciplinary Research Methods Core
NYU Langone Health - Associate Professor, Department of Population Health
Email: Charles.Cleland@nyulangone.org
Education
PhD, Psychology, New School for Social Research
MA, Psychology, New School for Social Research
BA, Psychology, Hampden-Sydney College

Research Interests
HIV prevention, Health disparities, Substance use, Sexual health, Longitudinal data analysis
BIO
Charles Cleland is a quantitative psychologist and biostatistician with more than ten years of experience in the field of public health research. His methodological interests include longitudinal data analysis, meta­-analysis, respondent­ driven sampling, and multilevel modeling. His substantive research interests include health disparities, particularly in the areas of substance use and infectious disease.
Publications

Recent

Jones T, Luth EA, Cleland CM, Brody AA (2025).
Race and ethnicity, neighborhood social deprivation and Medicare home health agency quality for persons living with serious illness
American Journal of Hospice and Palliative Medicine [Epub 2025 Jan 27]. doi: 10.1177/10499091251316309.

Cluesman SR, Gwadz M, Cleland CM (2025).
Intentions to use PrEP among a national sample of transgender and gender-expansive youth and emerging adults: Examining gender minority stress, substance use, and gender affirmation
AIDS and Behavior [Epub 2025 Jan 17]. doi: 10.1007/s10461-025-04613-1.

Yang KH, Kepner W, Cleland CM, Palamar JJ (2025).
Trends and characteristics in ketamine use among US adults with and without depression, 2015-2022
Journal of Affective Disorders, 373, 345-352. doi: 10.1016/j.jad.2024.12.108.

Frank D, Bennett AS, Cleland CM, Meyerson BE, Russell DM, Walters SM, Simon C, Scheidell JD, Elliott L (2025).
“I still can feel the sickness”: Withdrawal experiences of people on methadone maintenance treatment
Journal of Substance Use and Addiction Treatment, 170, 209616. doi: 10.1016/j.josat.2024.209616.

Gaeta Gazzola M, Torsiglieri A, Velez L, Blaufarb S, Hernandez P, O'Grady MA, Blackburn J, Florick J, Cleland CM, Shelley D, Doran KM (2025).
A community-academic partnership to develop an implementation support package for overdose prevention in permanent supportive housing
Journal of Substance Use and Addiction Treatment, 168, 209533. doi: 10.1016/j.josat.2024.209533.


Notable

Kurth AE, Spielberg F, Cleland CM, Lambdin B, Bangsberg DR, Frick PA, Severynen AO, Clausen M, Norman RG, Lockhart D, Simoni JM, Holmes KK (2014).
Computerized counseling reduces HIV-1 viral load and sexual transmission risk: Findings from a randomized controlled trial
Journal of Acquired Immune Deficiency Syndromes, 65 (5), 611-620. doi: 10.1097/QAI.0000000000000100. PMCID: PMC3999203.

Marsch LA, Guarino H, Acosta M, Aponte-Melendez Y, Cleland C, Grabinski M, Brady R, Edwards J (2014).
Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment
Journal of Substance Abuse Treatment, 46 (1), 43-51. doi: 10.1016/j.jsat.2013.08.012. PMCID: PMC3839618 .

Rosenblum A, Joseph H, Fong, C, Kipnis S, Cleland CM, Portenoy RK (2003).
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities
Journal of the American Medical Association, 289 (18), 2370-2378. doi: 10.1001/jama.289.18.2370.

Dr. Cleland's Research Gate Profile
Selected Press